Citation Impact
Citing Papers
Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faecium
2002
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
An Engineered Microbial Platform for Direct Biofuel Production from Brown Macroalgae
2012 StandoutScienceNobel
Using Bacteriophages To Reduce Formation of Catheter-Associated Biofilms by Staphylococcus epidermidis
2006
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
2000
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
2017
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
2019 Standout
Bacteriophage Therapy in Implant-Related Infections
2013
Use of bacteriophages in the treatment ofPseudomonas aeruginosainfections
2013
Phage therapy reduces Campylobacter jejuni colonization in broilers
2005
Non-antibiotic therapies for infectious diseases
2003
Syndemics and the biosocial conception of health
2017 Standout
Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries
1996
Population and evolutionary dynamics of phage therapy
2004
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy
2009 Standout
Guidelines for the Prevention of Intravascular Catheter–Related Infections
2002
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections
2017
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
2013
Preventing biofilms of clinically relevant organisms using bacteriophage
2009
Bacteriophage resistance mechanisms
2010 Standout
Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env
2011
Ecology of prokaryotic viruses
2003 Standout
β-Neurexin Is a Ligand for the Staphylococcus aureus MSCRAMM SdrC
2010 StandoutNobel
The Rationale for Using Bacteriophage to Treat and Prevent Periprosthetic Joint Infections
2020
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
2014
A review of stimuli-responsive nanocarriers for drug and gene delivery
2008 Standout
Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection
2018
Biofilms and Antimicrobial Resistance
2005
Two New Lytic Bacteriophages of the Myoviridae Family Against Carbapenem-Resistant Acinetobacter baumannii
2018
A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections
2016
Antibiotic resistance of bacterial biofilms
2010 Standout
Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model
2016
The threat of antimicrobial resistance in developing countries: causes and control strategies
2017 Standout
The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90
2005
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
2003
Biofilm Matrix-Degrading Enzymes
2014
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Biofilms: an emergent form of bacterial life
2016 Standout
Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
2009
Bacteriophage and their lysins for elimination of infectious bacteria
2009
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
The biofilm matrix
2010 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Role of polysaccharides in Pseudomonas aeruginosa biofilm development
2007
Phage treatment of human infections
2011
Bacteriophage applications: where are we now?
2010
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Antiviral properties of extract of opuntia streptacantha
1996
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
2017
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future
2010 Standout
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
The next generation of bacteriophage therapy
2011
<p>Mechanistic research holds promise for bacterial vaccines and phage therapies for <em>Pseudomonas aeruginosa</em></p>
2019
Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
2018
Electrospinning: A Fascinating Method for the Preparation of Ultrathin Fibers
2007 Standout
Bacteriophages: an appraisal of their role in the treatment of bacterial infections
2007
Bacteriophage therapy — cooked goose or Phoenix rising?
2008
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Display technologies: Application for the discovery of drug and gene delivery agents☆
2006
Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa
2009
Vascular Targeting: Recent Advances and Therapeutic Perspectives
2006
Infective endocarditis
2004 Standout
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
Phage antibacterials make a comeback
2001
Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments
2012
Marine viruses — major players in the global ecosystem
2007 Standout
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
Biological effects of essential oils – A review
2007 Standout
Fabrication of novel biomaterials through molecular self-assembly
2003 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
SLPW: A Virulent Bacteriophage Targeting Methicillin-Resistant Staphylococcus aureus In vitro and In vivo
2016
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Encapsulation of bacteria and viruses in electrospun nanofibres
2006
Bacteriophage Therapy
2001
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria
2017
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections
2016
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
2003 Standout
Bacteriophage Therapy
2001
Viruses as pathogens of marine organisms—from bacteria to whales
2006
Enzymes for Antifouling Strategies
2011
Plant Products as Antimicrobial Agents
1999 Standout
The Pathogenic Potential of a Microbe
2017
Global Epidemiology of Campylobacter Infection
2015 Standout
Reduction in Exopolysaccharide Viscosity as an Aid to Bacteriophage Penetration through Pseudomonas aeruginosa Biofilms
2001
Alginate Lyase: Review of Major Sources and Enzyme Characteristics, Structure-Function Analysis, Biological Roles, and Applications
2000
Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa
2006
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
BODIPY dyes in photodynamic therapy
2012 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Phage Therapy Revisited: The Population Biology of a Bacterial Infection and Its Treatment with Bacteriophage and Antibiotics
1996
The oral microbiota: dynamic communities and host interactions
2018 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Designing Photosensitizers for Photodynamic Therapy: Strategies, Challenges and Promising Developments
2009
The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics
1997
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Works of James S. Soothill being referenced
Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoidPseudomonas aeruginosa
1997
Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients
2006
Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
1994
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential
1997
Treatment of experimental infections of mice with bacteriophages
1992
A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: A pediatric single center before/after study on a hemopoietic stem cell transplant ward
2009
The effect of human lactoferrin on the MICs of doxycycline and rifampicin for Burkholderia cepacia and Pseudomonas aeruginosa strains
1999
Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms
2006
The IC50: an exactly defined measure of antibiotic sensitivity
1992
Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model
2005
The HID50 (hypothermia-inducing dose 50): an alternative to the LD50 for measurement of bacterial virulence.
1992